BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31944535)

  • 21. Clinical significance of CCNE1 copy number gain in acral melanoma patients.
    Wu X; Yan J; Yu J; Cheng Z; Guo Q; Kong Y; Guo J
    Melanoma Res; 2021 Aug; 31(4):352-357. PubMed ID: 33965974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma.
    Chang JW; Huang CJ; Huang WK; Wang YC; Hsieh JJ; Chang YY; Huang YL; Wu CL; Wang YH; Chen SJ; Tan KT; Chen CP; Wu CE
    Clin Transl Immunology; 2023; 12(8):e1465. PubMed ID: 37649975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acral melanoma: new insights into the immune and genomic landscape.
    Carvalho LAD; Aguiar FC; Smalley KSM; Possik PA
    Neoplasia; 2023 Dec; 46():100947. PubMed ID: 37913653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncommon Subtypes of Malignant Melanomas: A Review Based on Clinical and Molecular Perspectives.
    Chacón M; Pfluger Y; Angel M; Waisberg F; Enrico D
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Stage Melanoma of the Vermillion with Mucosal Melanoma in Situ: A Clinical Conundrum.
    Betz SJ; Jelmini JJ; Kim RY
    Head Neck Pathol; 2023 Sep; 17(3):815-820. PubMed ID: 37204685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational landscape and predictors of survival in head and neck mucosal melanoma.
    Lehrich BM; Abiri A; Nguyen TV; Bitner BF; Tong CCL; Kuan EC
    Int Forum Allergy Rhinol; 2024 Apr; 14(4):858-861. PubMed ID: 37676479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of cultured primary acral melanoma cells and animal models for Chinese patients.
    Hu R; Zhao S; Su J; Chen X; Yin M
    Pigment Cell Melanoma Res; 2021 Nov; 34(6):1131-1137. PubMed ID: 34097822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure.
    Vicente ALSA; Novoloaca A; Cahais V; Awada Z; Cuenin C; Spitz N; Carvalho AL; Evangelista AF; Crovador CS; Reis RM; Herceg Z; de Lima Vazquez V; Ghantous A
    Nat Commun; 2022 Jul; 13(1):4115. PubMed ID: 35840550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic evolution of acral melanoma.
    Wang M; Fukushima S; Sheen YS; Ramelyte E; Pacheco NC; Shi C; Liu S; Banik I; Aquino JD; Acosta MS; Levesque M; Dummer R; Liau JY; Chu CY; Shain AH; Yeh I; Bastian BC
    bioRxiv; 2023 Oct; ():. PubMed ID: 37904969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the Clinical and Molecular Profiles of Subungual Melanoma and Acral Melanoma in Asian Patients.
    Ahn SY; Bae GE; Park SY; Yeo MK
    Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.
    Testa U; Castelli G; Pelosi E
    Med Sci (Basel); 2017 Nov; 5(4):. PubMed ID: 29156643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous and Mucosal Melanomas of Uncommon Sites: Where Do We Stand Now?
    Dika E; Lambertini M; Pellegrini C; Veronesi G; Melotti B; Riefolo M; Sperandi F; Patrizi A; Ricci C; Mussi M; Fargnoli MC
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33525348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tumor genetics of acral melanoma: What should a dermatologist know?
    Tod BM; Schneider JW; Bowcock AM; Visser WI; Kotze MJ
    JAAD Int; 2020 Dec; 1(2):135-147. PubMed ID: 34355205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Analysis of Murine Kit
    Everdell E; Ji Z; Njauw CN; Tsao H
    JID Innov; 2024 May; 4(3):100266. PubMed ID: 38585193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies.
    Scatena C; Murtas D; Tomei S
    Front Oncol; 2021; 11():635488. PubMed ID: 34123788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic structural variants drive distinct modes of oncogenesis in melanoma.
    Conway JR; Gillani R; Crowdis J; Reardon B; Park J; Han SH; Titchen BM; Benamar M; Haq R; Van Allen EM
    J Clin Invest; 2024 May; ():. PubMed ID: 38758740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combatting mucosal melanoma: recent advances and future perspectives.
    Tyrrell H; Payne M
    Melanoma Manag; 2018 Sep; 5(3):MMT11. PubMed ID: 30459941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cerebral melanoma: An exceptional localization in a case report.
    Sghier AB; Samba S; Bouabid M; Mouhib N; Berhili S; Moukhlissi M; Mezouar L
    Radiol Case Rep; 2024 May; 19(5):1674-1678. PubMed ID: 38384706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of chronic mechanical stress on the distribution and delineation of plantar acral melanomas.
    Garcia LC; Bittencourt FV
    Int J Dermatol; 2024 Apr; ():. PubMed ID: 38602086
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to PD-1 blockade in a patient with mucosal melanoma of the middle ear: Case report.
    Komatsuda H; Kumai T; Ueda S; Hirata-Nozaki Y; Hayashi T; Harabuchi Y
    Clin Case Rep; 2020 Dec; 8(12):3468-3471. PubMed ID: 33363953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.